The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

• Andersen KG
• Rambaut A
• Lipkin WI
• Holmes EC
• Garry RF

The proximal origin of SARS-CoV-2.

Nat Med. 2020; 26: 450-452

COVID-19 coronavirus pandemic.

• Johns Hopkins College of Drugs

COVID-19 dashboard by the Heart for Programs Science and Engineering (CSS) at Johns Hopkins College (JHU).

• Carfì A
• Bernabei R
• Landi F
• Gemelli In opposition to COVID-19 Put up-Acute Care Examine Group

Persistent signs in sufferers after acute COVID-19.

JAMA. 2020; 324: 603-605

• Helms J
• Kremer S
• Merdji H
• et al.

Neurologic options in extreme SARS-CoV-2 an infection.

N Engl J Med. 2020; 382: 2268-2270

Long run respiratory problems of covid-19.

BMJ. 2020; 370m3001

• The Editors of the Lancet Group

Studying from a retraction.

Lancet. 2020; 3961056

• Rochwerg B
• Parke R
• Murthy S
• et al.

Misinformation in the course of the coronavirus illness 2019 outbreak: how information emerges from noise.

Crit Care Explor. 2020; 2e0098

The Dialog: Coronavirus analysis carried out too quick is testing publishing safeguards, unhealthy science is getting by.

Scientists lower peer-review corners below stress of COVID-19 pandemic.

• Osuchowski MF
• Aletti F
• Cavaillon JM
• et al.

SARS-CoV-2/COVID-19: evolving actuality, world response, information gaps, and alternatives.

Shock. 2020; 54: 416-437

• Facilities for Illness Management and Prevention

Regularly requested questions on SARS.

Center East respiratory syndrome coronavirus (MERS-CoV) – The Kingdom of Saudi Arabia.

• Thoms M
• Buschauer R
• Ameismeier M
• et al.

Structural foundation for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.

Science. 2020; 369: 1249-1255

Evasion of sort I interferon by SARS-CoV-2.

Cell Rep. 2020; 33108234

Mechanisms of SARS-CoV-2 transmission and pathogenesis.

Developments Immunol. 2020; 41: 1100-1115

Detection of SARS-CoV-2 in several types of scientific specimens.

JAMA. 2020; 323: 1843-1844

• Xiao F
• Tang M
• Zheng X
• Liu Y
• Li X
• Shan H

Proof for gastrointestinal an infection of SARS-CoV-2.

Gastroenterology. 2020; 158: 1831-1833.e3

• Stanifer ML
• Kee C
• Cortese M
• et al.

Essential function of sort III interferon in controlling SARS-CoV-2 an infection in human intestinal epithelial cells.

Cell Rep. 2020; 32107863

• Chu H
• Zhou J
• Wong BH
• et al.

Productive replication of Center East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response.

Virology. 2014; 454–455: 197-205

• Cheung CY
• Poon LL
• Ng IH
• et al.

Cytokine responses in extreme acute respiratory syndrome coronavirus-infected macrophages in vitro: potential relevance to pathogenesis.

J Virol. 2005; 79: 7819-7826

Lively replication of Center East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis.

J Infect Dis. 2014; 209: 1331-1342

• Chen Y
• Feng Z
• Diao B
• et al.

The novel extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) straight decimates human spleens and lymph nodes.

medRxiv. 2020; ()

• Wang C
• Xie J
• Zhao L
• et al.

Alveolar macrophage dysfunction and cytokine storm within the pathogenesis of two extreme COVID-19 sufferers.

EBioMedicine. 2020; 57102833

• Wölfel R
• Corman VM
• Guggemos W
• et al.

Virological evaluation of hospitalized sufferers with COVID-2019.

Nature. 2020; 581: 465-469

• Rockx B
• Kuiken T
• Herfst S
• et al.

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate mannequin.

Science. 2020; 368: 1012-1015

• Peiris JSM
• Chu CM
• Cheng VCC
• et al.

Medical development and viral load in a neighborhood outbreak of coronavirus-associated SARS pneumonia: a potential examine.

Lancet. 2003; 361: 1767-1772

• Pan Y
• Zhang D
• Yang P
• Poon LLM
• Wang Q

Viral load of SARS-CoV-2 in scientific samples.

Lancet Infect Dis. 2020; 20: 411-412

Temporal dynamics in viral shedding and transmissibility of COVID-19.

Nat Med. 2020; 26: 672-675

• Corman VM
• Albarrak AM
• Omrani AS
• et al.

Viral shedding and antibody response in 37 sufferers with Center East respiratory syndrome coronavirus an infection.

Clin Infect Dis. 2016; 62: 477-483

• Yilmaz A
• Marklund E
• Andersson M
• et al.

Higher respiratory tract ranges of SARS-CoV-2 RNA and period of viral RNA shedding don’t differ between sufferers with gentle and extreme/vital COVID-19.

J Infect Dis. 2021; 223: 15-18

• Chandrashekar A
• Liu J
• Martinot AJ
• et al.

SARS-CoV-2 an infection protects towards rechallenge in rhesus macaques.

Science. 2020; 369: 812-817

• Ni L
• Ye F
• Cheng M-L
• et al.

Detection of SARS-CoV-2-specific humoral and mobile immunity in COVID-19 convalescent people.

Immunity. 2020; 52: 971-977.e3

• Weis S
• Scherag A
• Baier M
• et al.

Antibody response utilizing six completely different serological assays in a totally PCR-tested neighborhood after a COVID-19 outbreak—the CoNAN examine.

Clin Microbiol Infect. 2021; 27: 470.e1-470.e9

• Sekine T
• Perez-Potti A
• Rivera-Ballesteros O
• et al.

Strong T cell immunity in convalescent people with asymptomatic or gentle COVID-19.

Cell. 2020; 183: 158-168.e14

• Ibarrondo FJ
• Fulcher JA
• Goodman-Meza D
• et al.

Fast decay of anti-SARS-CoV-2 antibodies in individuals with gentle Covid-19.

N Engl J Med. 2020; 383: 1085-1087

• Cao W-C
• Liu W
• Zhang P-H
• Zhang F
• Richardus JH

Disappearance of antibodies to SARS-associated coronavirus after restoration.

N Engl J Med. 2007; 357: 1162-1163

• Tang F
• Quan Y
• Xin ZT
• et al.

Lack of peripheral reminiscence B cell responses in recovered sufferers with extreme acute respiratory syndrome: a six-year follow-up examine.

J Immunol. 2011; 186: 7264-7268

• Wu LP
• Wang NC
• Chang YH
• et al.

Period of antibody responses after extreme acute respiratory syndrome.

Emerg Infect Dis. 2007; 13: 1562-1564

• Guo X
• Guo Z
• Duan C
• et al.

Lengthy-term persistence of IgG antibodies in SARS-CoV contaminated healthcare staff.

medRxiv. 2020; ()

• Dan JM
• Mateus J
• Kato Y
• et al.

Immunological reminiscence to SARS-CoV-2 assessed for as much as 8 months after an infection.

Science. 2021; 371eabf4063

• Le Bert N
• Tan AT
• Kunasegaran Ok
• et al.

SARS-CoV-2-specific T cell immunity in instances of COVID-19 and SARS, and uninfected controls.

Nature. 2020; 584: 457-462

SARS-CoV-2 T cell immunity: specificity, perform, sturdiness, and function in safety.

Sci Immunol. 2020; 5eabd6160

• Mateus J
• Grifoni A
• Tarke A
• et al.

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed people.

Science. 2020; 370: 89-94

Antibodies induced by receptor-binding area in spike protein of SARS-CoV don’t cross-neutralize the novel human coronavirus hCoV-EMC.

J Infect. 2013; 67: 348-350

• Che XY
• Qiu LW
• Liao ZY
• et al.

Antigenic cross-reactivity between extreme acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.

J Infect Dis. 2005; 191: 2033-2037

• Chan KH
• Cheng VC
• Woo PC
• et al.

Serological responses in sufferers with extreme acute respiratory syndrome coronavirus an infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.

Clin Diagn Lab Immunol. 2005; 12: 1317-1321

• Lv H
• Wu NC
• Tsang OT-Y
• et al.

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.

Cell Rep. 2020; 31107725

• Premkumar L
• Segovia-Chumbez B
• Jadi R
• et al.

The receptor binding area of the viral spike protein is an immunodominant and extremely particular goal of antibodies in SARS-CoV-2 sufferers.

Sci Immunol. 2020; 5eabc8413

vWei P-F, ed. Analysis and remedy protocol for novel coronavirus pneumonia (trial model 7). Chin Med J (Engl) 2020; 133: 1087–95.

• Epidemiology Working Group for NCIP Epidemic Response
• Chinese language Heart for Illness Management and Prevention

The epidemiological traits of an outbreak of 2019 novel coronavirus illnesses (COVID-19) in China.

Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 145-151

• Hou YJ
• Okuda Ok
• Edwards CE
• et al.

SARS-CoV-2 reverse genetics reveals a variable an infection gradient within the respiratory tract.

Cell. 2020; 182: 429-446.e14

• Tang X
• Du RH
• Wang R
• et al.

Comparability of hospitalized sufferers with ARDS brought on by COVID-19 and H1N1.

Chest. 2020; 158: 195-205

• Ellinghaus D
• Degenhardt F
• Bujanda L
• et al.

Genomewide affiliation examine of extreme Covid-19 with respiratory failure.

N Engl J Med. 2020; 383: 1522-1534

• Siswanto GM
• Gani M
• Fauzi AR
• et al.

Potential silent hypoxemia in a COVID-19 affected person: a case report.

Ann Med Surg (Lond). 2020; 60: 583-586

• Dhont S
• Derom E
• Van Braeckel E
• Depuydt P
• Lambrecht BN

The pathophysiology of ‘joyful’ hypoxemia in COVID-19.

Respir Res. 2020; 21: 198

• Guan WJ
• Ni ZY
• Hu Y
• et al.

Medical traits of coronavirus illness 2019 in China.

N Engl J Med. 2020; 382: 1708-1720

• Manning HL
• Schwartzstein RM

Pathophysiology of dyspnea.

N Engl J Med. 1995; 333: 1547-1553

Measuring the ventilatory response to hypoxia.

J Physiol. 2007; 584: 285-293

• Brochard L
• Slutsky A
• Pesenti A

Mechanical air flow to attenuate development of lung harm in acute respiratory failure.

Am J Respir Crit Care Med. 2017; 195: 438-442

• Tobin MJ
• Laghi F
• Jubran A

Why COVID-19 silent hypoxemia is baffling to physicians.

Am J Respir Crit Care Med. 2020; 202: 356-360

Irregular pulmonary perform in COVID-19 sufferers at time of hospital discharge.

Eur Respir J. 2020; 552001217

• Lang M
• Som A
• Mendoza DP
• et al.

Hypoxaemia associated to COVID-19: vascular and perfusion abnormalities on dual-energy CT.

Lancet Infect Dis. 2020; 20: 1365-1366

• Westblade LF
• Brar G
• Pinheiro LC
• et al.

SARS-CoV-2 viral load predicts mortality in sufferers with and with out most cancers who’re hospitalized with COVID-19.

Most cancers Cell. 2020; 38: 661-671.e2

• Magleby R
• Westblade LF
• Trzebucki A
• et al.

Influence of SARS-CoV-2 viral load on threat of intubation and mortality amongst hospitalized sufferers with coronavirus illness 2019.

Clin Infect Dis. 2020; ()

• Hikmet F
• Méar L
• Edvinsson Å
• Micke P
• Uhlén M
• Lindskog C

The protein expression profile of ACE2 in human tissues.

Mol Syst Biol. 2020; 16e9610

• Hoffmann M
• Kleine-Weber H
• Schroeder S
• et al.

SARS-CoV-2 cell entry relies on ACE2 and TMPRSS2 and is blocked by a clinically confirmed protease inhibitor.

Cell. 2020; 181: 271-280.e8

• Dickson RP
• Erb-Downward JR
• Martinez FJ
• Huffnagle GB

The microbiome and the respiratory tract.

Annu Rev Physiol. 2016; 78: 481-504

Airborne transmission of SARS-CoV-2: the world ought to face the truth.

Environ Int. 2020; 139105730

• Wilson NM
• Norton A
• Younger FP
• Collins DW

Airborne transmission of extreme acute respiratory syndrome coronavirus-2 to healthcare staff: a story assessment.

Anaesthesia. 2020; 75: 1086-1095

• Cantuti-Castelvetri L
• Ojha R
• Pedro LD
• et al.

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.

Science. 2020; 370: 856-860

• Wang S
• Qiu Z
• Hou Y
• et al.

AXL is a candidate receptor for SARS-CoV-2 that promotes an infection of pulmonary and bronchial epithelial cells.

Cell Res. 2021; 31: 126-140

• Carsana L
• Sonzogni A
• Nasr A
• et al.

Pulmonary autopsy findings in a sequence of COVID-19 instances from northern Italy: a two-centre descriptive examine.

Lancet Infect Dis. 2020; 20: 1135-1140

• Hellman U
• Karlsson MG
• Engström-Laurent A
• et al.

Presence of hyaluronan in lung alveoli in extreme Covid-19: a gap for brand new remedy choices?.

J Biol Chem. 2020; 295: 15418-15422

• Yao XH
• He ZC
• Li TY
• et al.

Pathological proof for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge affected person.

Cell Res. 2020; 30: 541-543

• Ackermann M
• Verleden SE
• Kuehnel M
• et al.

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19.

N Engl J Med. 2020; 383: 120-128

• Prilutskiy A
• Kritselis M
• Shevtsov A
• et al.

SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis.

Am J Clin Pathol. 2020; 154: 466-474

• Nicholls JM
• Poon LL
• Lee KC
• et al.

Lung pathology of deadly extreme acute respiratory syndrome.

Lancet. 2003; 361: 1773-1778

• Sorbello M
• El-Boghdadly Ok
• Di Giacinto I
• et al.

The Italian coronavirus illness 2019 outbreak: suggestions from scientific observe.

Anaesthesia. 2020; 75: 724-732

• Gattinoni L
• Chiumello D
• Caironi P
• et al.

COVID-19 pneumonia: completely different respiratory therapies for various phenotypes?.

Intensive Care Med. 2020; 46: 1099-1102

• Tobin MJ
• Laghi F
• Jubran A

Warning about early intubation and mechanical air flow in COVID-19.

Ann Intensive Care. 2020; 10: 78

• Grasselli G
• Tonetti T
• Protti A
• et al.

Pathophysiology of COVID-19-associated acute respiratory misery syndrome: a multicentre potential observational examine.

Lancet Respir Med. 2020; 8: 1201-1208

• Gattinoni L
• Marini JJ
• Camporota L

The respiratory drive: an neglected tile of COVID-19 pathophysiology.

Am J Respir Crit Care Med. 2020; 202: 1079-1080

Pulmonary fibrosis: pathogenesis, etiology and regulation.

Mucosal Immunol. 2009; 2: 103-121

• Quartuccio L
• Semerano L
• Benucci M
• Boissier MC
• De Vita S

Pressing avenues within the remedy of COVID-19: focusing on downstream irritation to stop catastrophic syndrome.

Joint Bone Backbone. 2020; 87: 191-193

A possible remedy of COVID-19 with TGF-β blockade.

Int J Biol Sci. 2020; 16: 1954-1955

• Eapen MS
• Lu W
• Gaikwad AV
• et al.

Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?.

Eur Respir J. 2020; 562003167

Pathology and pathogenesis of extreme acute respiratory syndrome.

Am J Pathol. 2007; 170: 1136-1147

• Hui DS
• Joynt GM
• Wong KT
• et al.

Influence of extreme acute respiratory syndrome (SARS) on pulmonary perform, useful capability and high quality of life in a cohort of survivors.

Thorax. 2005; 60: 401-409

• Herridge MS
• Tansey CM
• Matté A
• et al.

Purposeful incapacity 5 years after acute respiratory misery syndrome.

N Engl J Med. 2011; 364: 1293-1304

• Hwang DM
• Chamberlain DW
• Poutanen SM
• Low DE
• Asa SL
• Butany J

Pulmonary pathology of extreme acute respiratory syndrome in Toronto.

Mod Pathol. 2005; 18: 1-10

• Guo Y
• Korteweg C
• McNutt MA
• Gu J

Pathogenetic mechanisms of extreme acute respiratory syndrome.

Virus Res. 2008; 133: 4-12

• Edler C
• Schröder AS
• Aepfelbacher M
• et al.

Dying with SARS-CoV-2 infection-an post-mortem examine of the primary consecutive 80 instances in Hamburg, Germany.

Int J Authorized Med. 2020; 134: 1275-1284

• Barton LM
• Duval EJ
• Stroberg E
• Ghosh S
• Mukhopadhyay S

COVID-19 autopsies, Oklahoma, USA.

Am J Clin Pathol. 2020; 153: 725-733

• Ojha V
• Mani A
• Pandey NN
• Sharma S
• Kumar S

CT in coronavirus illness 2019 (COVID-19): a scientific assessment of chest CT findings in 4410 grownup sufferers.

Eur Radiol. 2020; 30: 6129-6138

• Yu M
• Liu Y
• Xu D
• Zhang R
• Lan L
• Xu H

Prediction of the event of pulmonary fibrosis utilizing serial thin-section CT and scientific options in sufferers discharged after remedy for COVID-19 pneumonia.

Korean J Radiol. 2020; 21: 746-755

• Klok FA
• Kruip MJHA
• van der Meer NJM
• et al.

Incidence of thrombotic problems in critically ailing ICU sufferers with COVID-19.

Thromb Res. 2020; 191: 145-147

• Obi AT
• Barnes GD
• Napolitano LM
• Henke PK
• Wakefield TW

Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in extreme acute respiratory syndrome coronavirus 2 an infection.

J Vasc Surg Venous Lymphat Disord. 2021; 9: 23-35

• Obi AT
• Pannucci CJ
• Nackashi A
• et al.

Validation of the Caprini venous thromboembolism threat evaluation mannequin in critically ailing surgical sufferers.

JAMA Surg. 2015; 150: 941-948

• Burkhard-Koren NM
• Haberecker M
• Maccio U
• et al.

Greater prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: post-mortem outcomes from ‘Spanish flu’ 1918/1919 in Switzerland to Coronavirus illness 2019.

J Pathol Clin Res. 2021; 7: 135-143

Threat elements related to acute respiratory misery syndrome and dying in sufferers with coronavirus illness 2019 pneumonia in Wuhan, China.

JAMA Intern Med. 2020; 180: 934-943

Medical course and threat elements for mortality of grownup inpatients with COVID-19 in Wuhan, China: a retrospective cohort examine.

Lancet. 2020; 395: 1054-1062

• Chen T
• Wu D
• Chen H
• et al.

Medical traits of 113 deceased sufferers with coronavirus illness 2019: retrospective examine.

BMJ. 2020; 368m1091

• Goyal P
• Choi JJ
• Pinheiro LC
• et al.

Medical traits of Covid-19 in New York Metropolis.

N Engl J Med. 2020; 382: 2372-2374

• Thachil J
• Tang N
• Gando S
• et al.

ISTH interim steerage on recognition and administration of coagulopathy in COVID-19.

J Thromb Haemost. 2020; 18: 1023-1026

• Leisman DE
• Ronner L
• Pinotti R
• et al.

Cytokine elevation in extreme and important COVID-19: a speedy systematic assessment, meta-analysis, and comparability with different inflammatory syndromes.

Lancet Respir Med. 2020; 8: 1233-1244

Laboratory abnormalities in sufferers with COVID-2019 an infection.

Clin Chem Lab Med. 2020; 58: 1131-1134

• Jirak P
• Larbig R
• Shomanova Z
• et al.

Myocardial harm in extreme COVID-19 is just like pneumonias of different origin: outcomes from a multicentre examine.

ESC Coronary heart Fail. 2021; 8: 37-46

• Mazzoni A
• Salvati L
• Maggi L
• et al.

Impaired immune cell cytotoxicity in extreme COVID-19 is IL-6 dependent.

J Clin Make investments. 2020; 130: 4694-4703

• Varga Z
• Flammer AJ
• Steiger P
• et al.

Endothelial cell an infection and endotheliitis in COVID-19.

Lancet. 2020; 395: 1417-1418

• Bösmüller H
• Traxler S
• Bitzer M
• et al.

The evolution of pulmonary pathology in deadly COVID-19 illness: an post-mortem examine with scientific correlation.

Virchows Arch. 2020; 477: 349-357

• Schaefer IM
• Padera RF
• Solomon IH
• et al.

In situ detection of SARS-CoV-2 in lungs and airways of sufferers with COVID-19.

Mod Pathol. 2020; 33: 2104-2114

Renal histopathological evaluation of 26 postmortem findings of sufferers with COVID-19 in China.

Kidney Int. 2020; 98: 219-227

• Buja LM
• Wolf DA
• Zhao B
• et al.

The rising spectrum of cardiopulmonary pathology of the coronavirus illness 2019 (COVID-19): report of three autopsies from Houston, Texas, and assessment of post-mortem findings from different United States cities.

Cardiovasc Pathol. 2020; 48107233

• Sadegh Beigee F
• Pourabdollah Toutkaboni M
• Khalili N
• et al.

Diffuse alveolar harm and thrombotic microangiopathy are the primary histopathological findings in lung tissue biopsy samples of COVID-19 sufferers.

Pathol Res Pract. 2020; 216153228

• Iba T
• Levy JH
• Connors JM
• Warkentin TE
• Thachil J
• Levi M

The distinctive traits of COVID-19 coagulopathy.

Crit Care. 2020; 24: 360

• Copin MC
• Parmentier E
• Duburcq T
• Poissy J
• Mathieu D

Time to contemplate histologic sample of lung harm to deal with critically ailing sufferers with COVID-19 an infection.

Intensive Care Med. 2020; 46: 1124-1126

• McGonagle D
• O’Donnell JS
• Sharif Ok
• Emery P
• Bridgewood C

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.

Lancet Rheumatol. 2020; 2: e437-e445

• Arachchillage DJ
• Stacey A
• Akor F
• Scotz M
• Laffan M

Thrombolysis restores perfusion in COVID-19 hypoxia.

Br J Haematol. 2020; 190: e270-e274

• Zhang Y
• Xiao M
• Zhang S
• et al.

Coagulopathy and antiphospholipid antibodies in sufferers with Covid-19.

N Engl J Med. 2020; 382: e38

Medical traits of 138 hospitalized sufferers with 2019 novel coronavirus-infected pneumonia in Wuhan, China.

JAMA. 2020; 323: 1061-1069

• Botta M
• Tsonas AM
• Pillay J
• et al.

Air flow administration and scientific outcomes in invasively ventilated sufferers with COVID-19 (PRoVENT-COVID): a nationwide, multicentre, observational cohort examine.

Lancet Respir Med. 2021; 9: 139-148

• Sinha P
• Calfee CS
• Cherian S
• et al.

Prevalence of phenotypes of acute respiratory misery syndrome in critically ailing sufferers with COVID-19: a potential observational examine.

Lancet Respir Med. 2020; 8: 1209-1218

• Puelles VG
• Lütgehetmann M
• Lindenmeyer MT
• et al.

Multiorgan and renal tropism of SARS-CoV-2.

N Engl J Med. 2020; 383: 590-592

• Wichmann D
• Sperhake JP
• Lütgehetmann M
• et al.

Post-mortem findings and venous thromboembolism in sufferers with COVID-19: a potential cohort examine.

Ann Intern Med. 2020; 173: 268-277

• Gill SE
• Dos Santos CC
• O’Gorman DB
• et al.

Transcriptional profiling of leukocytes in critically ailing COVID19 sufferers: implications for interferon response and coagulation.

Intensive Care Med Exp. 2020; 8: 75

• Deinhardt-Emmer S
• Wittschieber D
• Sanft J
• et al.

Early postmortem mapping of SARS-CoV-2 RNA in sufferers with COVID-19 and the correlation with tissue harm.

Elife. 2021; 10e60361

• South AM
• Diz DI
• Chappell MC

COVID-19, ACE2, and the cardiovascular penalties.

Am J Physiol Coronary heart Circ Physiol. 2020; 318: H1084-H1090

Mechanisms and remedy of organ failure in sepsis.

Nat Rev Nephrol. 2018; 14: 417-427

• Gupta A
• Madhavan MV
• Sehgal Ok
• et al.

Extrapulmonary manifestations of COVID-19.

Nat Med. 2020; 26: 1017-1032

• Onofrio L
• Caraglia M
• Facchini G
• Margherita V
• Placido S
• Buonerba C

Toll-like receptors and COVID-19: a two-faced story with an thrilling ending.

Future Sci OA. 2020; 6FSO605

• Totura AL
• Whitmore A
• Agnihothram S
• et al.

Toll-like receptor 3 signaling by way of TRIF contributes to a protecting innate immune response to extreme acute respiratory syndrome coronavirus an infection.

MBio. 2015; 6: e00638-e00715

• van der Made CI
• Simons A
• Schuurs-Hoeijmakers J
• et al.

Presence of genetic variants amongst younger males with extreme COVID-19.

JAMA. 2020; 324: 663-673

• Zhang Q
• Bastard P
• Liu Z
• et al.

Inborn errors of sort I IFN immunity in sufferers with life-threatening COVID-19.

Science. 2020; 370eabd4570

Pathological irritation in sufferers with COVID-19: a key function for monocytes and macrophages.

Nat Rev Immunol. 2020; 20: 355-362

• Huang C
• Wang Y
• Li X
• et al.

Medical options of sufferers contaminated with 2019 novel coronavirus in Wuhan, China.

Lancet. 2020; 395: 497-506

• Bermejo-Martin JF
• González-Rivera M
• Almansa R
• et al.

Viral RNA load in plasma is related to vital sickness and a dysregulated host response in COVID-19.

Crit Care. 2020; 24: 691

• Sinha P
• Matthay MA
• Calfee CS

Is a “cytokine storm” related to COVID-19?.

JAMA Intern Med. 2020; 180: 1152-1154

• Chen X
• Zhao B
• Qu Y
• et al.

Detectable serum extreme acute respiratory syndrome coronavirus 2 viral load (RNAemia) is intently correlated with drastically elevated interleukin 6 stage in critically ailing sufferers with coronavirus illness 2019.

Clin Infect Dis. 2020; 71: 1937-1942

Immune cell profiling of COVID-19 sufferers within the restoration stage by single-cell sequencing.

Cell Discov. 2020; 6: 31

Diagnostic utility of scientific laboratory knowledge determinations for sufferers with the extreme COVID-19.

J Med Virol. 2020; 92: 791-796

• Ruan Q
• Yang Ok
• Wang W
• Jiang L
• Track J

Medical predictors of mortality resulting from COVID-19 based mostly on an evaluation of knowledge of 150 sufferers from Wuhan, China.

Intensive Care Med. 2020; 46: 846-848

• Balnis J
• Adam AP
• Chopra A
• et al.

Distinctive inflammatory profile is related to greater SARS-CoV-2 acute respiratory misery syndrome (ARDS) mortality.

Am J Physiol Regul Integr Comp Physiol. 2021; 320: R250-R257

Medical and immunologic options in extreme and reasonable coronavirus illness 2019.

J Clin Make investments. 2020; 130: 2620-2629

Immune cell profiling of COVID-19 sufferers within the restoration stage by single-cell sequencing.

Cell Discov. 2020; 6: 31

• Payen D
• Cravat M
• Maadadi H
• et al.

A longitudinal examine of immune cells in extreme COVID-19 sufferers.

Entrance Immunol. 2020; 11580250

• Giamarellos-Bourboulis EJ
• Netea MG
• Rovina N
• et al.

Complicated immune dysregulation in COVID-19 sufferers with extreme respiratory failure.

Cell Host Microbe. 2020; 27: 992-1000.e3

• Carter MJ
• Fish M
• Jennings A
• et al.

Peripheral immunophenotypes in kids with multisystem inflammatory syndrome related to SARS-CoV-2 an infection.

Nat Med. 2020; 26: 1701-1707

• Feldstein LR
• Rose EB
• Horwitz SM
• et al.

Multisystem inflammatory syndrome in U.S. kids and adolescents.

N Engl J Med. 2020; 383: 334-346

• Dufort EM
• Koumans EH
• Chow EJ
• et al.

Multisystem inflammatory syndrome in kids in New York State.

N Engl J Med. 2020; 383: 347-358

• Bastard P
• Rosen LB
• Zhang Q
• et al.

Autoantibodies towards sort I IFNs in sufferers with life-threatening COVID-19.

Science. 2020; 370eabd4585

• Hadjadj J
• Yatim N
• Barnabei L
• et al.

Impaired sort I interferon exercise and inflammatory responses in extreme COVID-19 sufferers.

Science. 2020; 369: 718-724

• Blanco-Melo D
• Nilsson-Payant BE
• Liu WC
• et al.

Imbalanced host response to SARS-CoV-2 drives growth of COVID-19.

Cell. 2020; 181: 1036-1045.e9

• Trouillet-Assant S
• Viel S
• Gaymard A
• et al.

Sort I IFN immunoprofiling in COVID-19 sufferers.

J Allergy Clin Immunol. 2020; 146: 206-208.e2

• Galani IE
• Rovina N
• Lampropoulou V
• et al.

Untuned antiviral immunity in COVID-19 revealed by temporal sort I/III interferon patterns and flu comparability.

Nat Immunol. 2021; 22: 32-40

• Lee JS
• Park S
• Jeong HW
• et al.

Immunophenotyping of COVID-19 and influenza highlights the function of sort I interferons in growth of extreme COVID-19.

Sci Immunol. 2020; 5eabd1554

• Kox M
• Waalders NJB
• Kooistra EJ
• Gerretsen J
• Pickkers P

Cytokine ranges in critically ailing sufferers with COVID-19 and different situations.

JAMA. 2020; 324: 1565-1567

• Monneret G
• Benlyamani I
• Gossez M
• et al.

COVID-19: What sort of cytokine storm are we coping with?.

J Med Virol. 2021; 93: 197-198

• Zhou Z
• Ren L
• Zhang L
• et al.

Heightened innate immune responses within the respiratory tract of COVID-19 sufferers.

Cell Host Microbe. 2020; 27: 883-890.e2

• Xiong Y
• Liu Y
• Cao L
• et al.

Transcriptomic traits of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 sufferers.

Emerg Microbes Infect. 2020; 9: 761-770

• Ronit A
• Berg RMG
• Bay JT
• et al.

Compartmental immunophenotyping in COVID-19 ARDS: a case sequence.

J Allergy Clin Immunol. 2021; 147: 81-91

• Carvelli J
• Demaria O
• Vély F
• et al.

Affiliation of COVID-19 irritation with activation of the C5a-C5aR1 axis.

Nature. 2020; 588: 146-150

• Yang L
• Han Y
• Nilsson-Payant BE
• et al.

A human pluripotent stem cell-based platform to review SARS-CoV-2 tropism and mannequin virus an infection in human cells and organoids.

Cell Stem Cell. 2020; 27: 125-136.e7

• Nienhold R
• Ciani Y
• Koelzer VH
• et al.

Two distinct immunopathological profiles in post-mortem lungs of COVID-19.

Nat Commun. 2020; 115086

• Toldo S
• Bussani R
• Nuzzi V
• et al.

Inflammasome formation within the lungs of sufferers with deadly COVID-19.

Inflamm Res. 2021; 70: 7-10

• Li MY
• Li L
• Zhang Y
• Wang XS

Expression of the SARS-CoV-2 cell receptor gene ACE2 in all kinds of human tissues.

Infect Dis Poverty. 2020; 9: 45

• Lachmann G
• Knaak C
• Vorderwülbecke G
• et al.

Hyperferritinemia in critically ailing sufferers.

Crit Care Med. 2020; 48: 459-465

• Kyriazopoulou E
• Leventogiannis Ok
• Norrby-Teglund A
• et al.

Macrophage activation-like syndrome: an immunological entity related to speedy development to dying in sepsis.

BMC Med. 2017; 15: 172

• Mesas AE
• Cavero-Redondo I
• Álvarez-Bueno C
• et al.

Predictors of in-hospital COVID-19 mortality: a complete systematic assessment and meta-analysis exploring variations by age, intercourse and well being situations.

PLoS One. 2020; 15e0241742

Ferritin within the coronavirus illness 2019 (COVID-19): a scientific assessment and meta-analysis.

J Clin Lab Anal. 2020; 34e23618

• Masetti C
• Generali E
• Colapietro F
• et al.

Excessive mortality in COVID-19 sufferers with gentle respiratory illness.

Eur J Clin Make investments. 2020; 50e13314

• Al-Samkari H
• Karp Leaf RS
• Dzik WH
• et al.

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 an infection.

Blood. 2020; 136: 489-500

• Huet T
• Beaussier H
• Voisin O
• et al.

Anakinra for extreme types of COVID-19: a cohort examine.

Lancet Rheumatol. 2020; 2: e393-e400

• Cavalli G
• De Luca G
• Campochiaro C
• et al.

Interleukin-1 blockade with high-dose anakinra in sufferers with COVID-19, acute respiratory misery syndrome, and hyperinflammation: a retrospective cohort examine.

Lancet Rheumatol. 2020; 2: e325-e331

• Dimopoulos G
• de Mast Q
• Markou N
• et al.

Favorable anakinra responses in extreme covid-19 sufferers with secondary hemophagocytic lymphohistiocytosis.

Cell Host Microbe. 2020; 28: 117-123.e1

• Vasquez-Bonilla WO
• Orozco R
• Argueta V
• et al.

A assessment of the primary histopathological findings in coronavirus illness 2019.

Hum Pathol. 2020; 105: 74-83

• Fardet L
• Galicier L
• Lambotte O
• et al.

Improvement and validation of the HScore, a rating for the analysis of reactive hemophagocytic syndrome.

Arthritis Rheumatol. 2014; 66: 2613-2620

Immune-inflammatory parameters in COVID-19 instances: a scientific assessment and meta-analysis.

Entrance Med (Lausanne). 2020; 7: 301

• Kox M
• Frenzel T
• Schouten J
• van de Veerdonk FL
• Koenen HJPM
• Pickkers P

COVID-19 sufferers exhibit much less pronounced immune suppression in contrast with bacterial septic shock sufferers.

Crit Care. 2020; 24: 263

• Cugno M
• Meroni PL
• Gualtierotti R
• et al.

Complement activation in sufferers with COVID-19: a novel therapeutic goal.

J Allergy Clin Immunol. 2020; 146: 215-217

• Holter JC
• Pischke SE
• de Boer E
• et al.

Systemic complement activation is related to respiratory failure in COVID-19 hospitalized sufferers.

Proc Natl Acad Sci USA. 2020; 117: 25018-25025

• Schuetz P
• Albrich W
• Mueller B

Procalcitonin for analysis of an infection and information to antibiotic choices: previous, current and future.

BMC Med. 2011; 9: 107

• Tujula B
• Hämäläinen S
• Kokki H
• Pulkki Ok
• Kokki M

Assessment of scientific observe pointers on the usage of procalcitonin in infections.

Infect Dis (Lond). 2020; 52: 227-234

• Bao J
• Li C
• Zhang Ok
• Kang H
• Chen W
• Gu B

Comparative evaluation of laboratory indexes of extreme and non-severe sufferers contaminated with COVID-19.

Clin Chim Acta. 2020; 509: 180-194

Essential laboratory parameters in COVID-19 analysis and prognosis: an up to date meta-analysis.

Med Clin (Barc). 2020; 155: 143-151

• van Berkel M
• Kox M
• Frenzel T
• Pickkers P
• Schouten J

Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 instances?.

Crit Care. 2020; 24: 600

Medical course and outcomes of critically ailing sufferers with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational examine.

Lancet Respir Med. 2020; 8: 475-481

• Apicella M
• Campopiano MC
• Mantuano M
• Mazoni L
• Coppelli A
• Del Prato S

COVID-19 in folks with diabetes: understanding the explanations for worse outcomes.

Lancet Diabetes Endocrinol. 2020; 8: 782-792

• Yang JK
• Feng Y
• Yuan MY
• et al.

Plasma glucose ranges and diabetes are impartial predictors for mortality and morbidity in sufferers with SARS.

Diabet Med. 2006; 23: 623-628

• Taneera J
• El-Huneidi W
• Hamad M
• Mohammed AK
• Elaraby E
• Hachim MY

Expression profile of SARS-CoV-2 host receptors in human pancreatic islets revealed upregulation of ACE2 in diabetic donors.

Biology (Basel). 2020; 9: E215

COVID-19 and the endocrine system: exploring the unexplored.

J Endocrinol Make investments. 2020; 43: 1027-1031

• Zhu L
• She ZG
• Cheng X
• et al.

Affiliation of blood glucose management and outcomes in sufferers with COVID-19 and pre-existing sort 2 diabetes.

Cell Metab. 2020; 31: 1068-1077.e3

Exploring illnesses/traits and blood proteins causally associated to expression of ACE2, the putative receptor of SARS-CoV-2: a mendelian randomization evaluation highlights tentative relevance of diabetes-related traits.

Diabetes Care. 2020; 43: 1416-1426

• Marshall RJ
• Armart P
• Hulme KD
• et al.

Glycemic variability in diabetes will increase the severity of influenza.

MBio. 2020; 11: e02841-e02849

• Nielsen TB
• Pantapalangkoor P
• Yan J
• et al.

Diabetes exacerbates an infection by way of hyperinflammation by signaling by TLR4 and RAGE.

MBio. 2017; 8: e00818-e00917

COVID-19, diabetes mellitus and ACE2: the conundrum.

Diabetes Res Clin Pract. 2020; 162108132

• Busse LW
• Chow JH
• McCurdy MT
• Khanna AK

COVID-19 and the RAAS-a potential function for angiotensin II?.

Crit Care. 2020; 24: 136

• Fosbøl EL
• Butt JH
• Østergaard L
• et al.

Affiliation of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 analysis and mortality.

JAMA. 2020; 324: 168-177

• Han Y
• Runge MS
• Brasier AR

Angiotensin II induces interleukin-6 transcription in vascular clean muscle cells by pleiotropic activation of nuclear factor-kappa B transcription elements.

Circ Res. 1999; 84: 695-703

• Franco R
• Rivas-Santisteban R
• Serrano-Marín J
• Rodríguez-Pérez AI
• Labandeira-García JL
• Navarro G

SARS-CoV-2 as an element to disbalance the renin-angiotensin system: a suspect within the case of exacerbated IL-6 manufacturing.

J Immunol. 2020; 205: 1198-1206

• Verdecchia P
• Cavallini C
• Spanevello A
• Angeli F

The pivotal hyperlink between ACE2 deficiency and SARS-CoV-2 an infection.

Eur J Intern Med. 2020; 76: 14-20

• Gebhard C
• Regitz-Zagrosek V
• Neuhauser HK
• Morgan R
• Klein SL

Influence of intercourse and gender on COVID-19 outcomes in Europe.

Biol Intercourse Differ. 2020; 11: 29

• Montopoli M
• Zumerle S
• Vettor R
• et al.

Androgen-deprivation therapies for prostate most cancers and threat of an infection by SARS-CoV-2: a population-based examine (N = 4532).

Ann Oncol. 2020; 31: 1040-1045

• Scully EP
• Haverfield J
• Ursin RL
• Tannenbaum C
• Klein SL

Contemplating how organic intercourse impacts immune responses and COVID-19 outcomes.

Nat Rev Immunol. 2020; 20: 442-447

Dysregulation of immune response in sufferers with Coronavirus 2019 (COVID-19) in Wuhan, China.

Clin Infect Dis. 2020; 71: 762-768

• Ma A
• Cheng J
• Yang J
• Dong M
• Liao X
• Kang Y

Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in extreme COVID-19 sufferers.

Crit Care. 2020; 24: 288

• Carissimo G
• Xu W
• Kwok I
• et al.

Entire blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for extreme COVID-19.

Nat Commun. 2020; 115243

• Kuri-Cervantes L
• Pampena MB
• Meng W
• et al.

Complete mapping of immune perturbations related to extreme COVID-19.

Sci Immunol. 2020; 5eabd7114

• Bordoni V
• Sacchi A
• Cimini E
• et al.

An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.

Clin Infect Dis. 2020; 71: 2272-2275

• Silvin A
• Chapuis N
• Dunsmore G
• et al.

Elevated calprotectin and irregular myeloid cell subsets discriminate extreme from gentle COVID-19.

Cell. 2020; 182: 1401-1418.e18

• Schulte-Schrepping J
• Reusch N
• Paclik D
• et al.

Extreme COVID-19 is marked by a dysregulated myeloid cell compartment.

Cell. 2020; 182: 1419-1440.e23

• Agrati C
• Sacchi A
• Bordoni V
• et al.

Growth of myeloid-derived suppressor cells in sufferers with extreme coronavirus illness (COVID-19).

Cell Loss of life Differ. 2020; 27: 3196-3207

• Brudecki L
• Ferguson DA
• McCall CE
• El Gazzar M

Myeloid-derived suppressor cells evolve throughout sepsis and may improve or attenuate the systemic inflammatory response.

Infect Immun. 2012; 80: 2026-2034

• Wilk AJ
• Rustagi A
• Zhao NQ
• et al.

A single-cell atlas of the peripheral immune response in sufferers with extreme COVID-19.

Nat Med. 2020; 26: 1070-1076

• Wang J
• Jiang M
• Chen X
• Montaner LJ

Cytokine storm and leukocyte modifications in gentle versus extreme SARS-CoV-2 an infection: assessment of 3939 COVID-19 sufferers in China and rising pathogenesis and remedy ideas.

J Leukoc Biol. 2020; 108: 17-41

• Zuo Y
• Yalavarthi S
• Shi H
• et al.

Neutrophil extracellular traps in COVID-19.

JCI Perception. 2020; 5e138999

• Barnes BJ
• Adrover JM
• Baxter-Stoltzfus A
• et al.

Focusing on potential drivers of COVID-19: Neutrophil extracellular traps.

J Exp Med. 2020; 217e20200652

• Carter MJ
• Fish M
• Jennings A
• et al.

Immunophenotyping of circulating leukocytes reveal non-specific activation of innate and adaptive immune methods in multi-system inflammatory syndrome of childhood temporally related to SARS-Cov-2 an infection: descriptive cohort examine.

Preprints. 2020; ()

• Payen D
• Cravat M
• Maadadi H
• et al.

A longitudinal examine of immune cells in extreme COVID-19 sufferers.

Entrance Immunol. 2020; 11580250

• Laing AG
• Lorenc A
• Del Molino Del Barrio I
• et al.

A dynamic COVID-19 immune signature contains associations with poor prognosis.

Nat Med. 2020; 26: 1623-1635

• Zhou Y
• Fu B
• Zheng X
• et al.

Pathogenic T cells and inflammatory monocytes incite inflammatory storm in extreme COVID-19 sufferers.

Natl Sci Rev. 2020; 7: 998-1002

• Liao M
• Liu Y
• Yuan J
• et al.

Single-cell panorama of bronchoalveolar immune cells in sufferers with COVID-19.

Nat Med. 2020; 26: 842-844

• Sanchez-Cerrillo I
• Landete P
• Aldave B
• et al.

COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.

J Clin Make investments. 2020; 130: 6290-6300

• Grant RA
• Morales-Nebreda L
• Markov NS
• et al.

Circuits between contaminated macrophages and T cells in SARS-CoV-2 pneumonia.

Nature. 2021; 590: 635-641

• Leijte GP
• Rimmelé T
• Kox M
• et al.

Monocytic HLA-DR expression kinetics in septic shock sufferers with completely different pathogens, websites of an infection and opposed outcomes.

Crit Care. 2020; 24: 110

• Torrance HDT
• Longbottom ER
• Vivian ME
• et al.

Put up-operative immune suppression is mediated by way of reversible, Interleukin-10 dependent pathways in circulating monocytes following main belly surgical procedure.

PLoS One. 2018; 13e0203795

• Cheron A
• Floccard B
• Allaouchiche B
• et al.

Lack of restoration in monocyte human leukocyte antigen-DR expression is independently related to the event of sepsis after main trauma.

Crit Care. 2010; 14: R208

• Monneret G
• Lepape A
• Voirin N
• et al.

Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.

Intensive Care Med. 2006; 32: 1175-1183

• Kim OY
• Monsel A
• Bertrand M
• Coriat P
• Cavaillon JM
• Adib-Conquy M

Differential down-regulation of HLA-DR on monocyte subpopulations throughout systemic irritation.

Crit Care. 2010; 14: R61

• Flohé S
• Lendemans S
• Schade FU
• Kreuzfelder E
• Waydhas C

Affect of surgical intervention within the immune response of severely injured sufferers.

Intensive Care Med. 2004; 30: 96-102

• Spinetti T
• Hirzel C
• Fux M
• et al.

Lowered monocytic human leukocyte antigen-DR expression signifies immunosuppression in critically ailing COVID-19 sufferers.

Anesth Analg. 2020; 131: 993-999

• Wang F
• Hou H
• Yao Y
• et al.

Systemically evaluating host immunity between survived and deceased COVID-19 sufferers.

Cell Mol Immunol. 2020; 17: 875-877

• Jeannet R
• Daix T
• Formento R
• Feuillard J
• François B

Extreme COVID-19 is related to deep and sustained multifaceted mobile immunosuppression.

Intensive Care Med. 2020; 46: 1769-1771

• Monneret G
• Cour M
• Viel S
• Venet F
• Argaud L

Coronavirus illness 2019 as a specific sepsis: a 2-week follow-up of normal immunological parameters in critically ailing sufferers.

Intensive Care Med. 2020; 46: 1764-1765

• Remy S
• Gossez M
• Belot A
• et al.

Huge enhance in monocyte HLA-DR expression can be utilized to discriminate between septic shock and hemophagocytic lymphohistiocytosis-induced shock.

Crit Care. 2018; 22: 213

• Le Tulzo Y
• Pangault C
• Amiot L
• et al.

Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol throughout septic shock.

Am J Respir Crit Care Med. 2004; 169: 1144-1151

The CD8 T cell response to respiratory virus infections.

Entrance Immunol. 2018; 9: 678

Decreased T cell populations contribute to the elevated severity of COVID-19.

Clin Chim Acta. 2020; 508: 110-114

As plain because the nostril in your face: the case for a nasal (mucosal) route of vaccine administration for Covid-19 illness prevention.

Entrance Immunol. 2020; 11591897

• Chen R
• Sang L
• Jiang M
• et al.

Longitudinal hematologic and immunologic variations related to the development of COVID-19 sufferers in China.

J Allergy Clin Immunol. 2020; 146: 89-100

• Jiang M
• Guo Y
• Luo Q
• et al.

T-cell subset counts in peripheral blood can be utilized as discriminatory biomarkers for analysis and severity prediction of coronavirus illness 2019.

J Infect Dis. 2020; 222: 198-202

Medical and immune options of hospitalized pediatric sufferers with coronavirus illness 2019 (COVID-19) in Wuhan, China.

JAMA Netw Open. 2020; 3e2010895

• De Biasi S
• Meschiari M
• Gibellini L
• et al.

Marked T cell activation, senescence, exhaustion and skewing in direction of TH17 in sufferers with COVID-19 pneumonia.

Nat Commun. 2020; 113434

• Wang F
• Nie J
• Wang H
• et al.

Traits of peripheral lymphocyte subset alteration in COVID-19 pneumonia.

J Infect Dis. 2020; 221: 1762-1769

• Shi H
• Wang W
• Yin J
• et al.

The inhibition of IL-2/IL-2R offers rise to CD8⁺ T cell and lymphocyte lower by JAK1-STAT5 in vital sufferers with COVID-19 pneumonia.

Cell Loss of life Dis. 2020; 11: 429

• Hou H
• Zhang B
• Huang H
• et al.

Utilizing IL-2R/lymphocytes for predicting the scientific development of sufferers with COVID-19.

Clin Exp Immunol. 2020; 201: 76-84

• Luo M
• Liu J
• Jiang W
• Yue S
• Liu H
• Wei S

IL-6 and CD8+ T cell counts mixed are an early predictor of in-hospital mortality of sufferers with COVID-19.

JCI Perception. 2020; 5e139024

• Urra JM
• Cabrera CM
• Porras L
• Ródenas I

Selective CD8 cell discount by SARS-CoV-2 is related to a worse prognosis and systemic irritation in COVID-19 sufferers.

Clin Immunol. 2020; 217108486

Longitudinal traits of lymphocyte responses and cytokine profiles within the peripheral blood of SARS-CoV-2 contaminated sufferers.

EBioMedicine. 2020; 55102763

• Wang F
• Hou H
• Luo Y
• et al.

The laboratory checks and host immunity of COVID-19 sufferers with completely different severity of sickness.

JCI Perception. 2020; 5e137799

• Remy KE
• Mazer M
• Striker DA
• et al.

Extreme immunosuppression and never a cytokine storm characterizes COVID-19 infections.

JCI Perception. 2020; 5e140329

• Gimenez E
• Albert E
• Torres I
• et al.

SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in sufferers hospitalized with coronavirus illness 2019.

J Med Virol. 2021; 93: 375-382

• Grifoni A
• Weiskopf D
• Ramirez SI
• et al.

Targets of T cell responses to SARS-CoV-2 coronavirus in people with COVID-19 illness and unexposed people.

Cell. 2020; 181: 1489-1501.e15

• Schaller T
• Hirschbühl Ok
• Burkhardt Ok
• et al.

Postmortem examination of sufferers with COVID-19.

JAMA. 2020; 323: 2518-2520

• Fajnzylber J
• Regan J
• Coxen Ok
• et al.

SARS-CoV-2 viral load is related to elevated illness severity and mortality.

Nat Commun. 2020; 115493

• Rouzé A
• Martin-Loeches I
• Povoa P
• et al.

Relationship between SARS-CoV-2 an infection and the incidence of ventilator-associated decrease respiratory tract infections: a European multicenter cohort examine.

Intensive Care Med. 2021; 47: 188-198

• Scharenberg M
• Vangeti S
• Kekäläinen E
• et al.

Influenza A virus an infection induces hyperresponsiveness in human lung tissue-resident and peripheral blood NK cells.

Entrance Immunol. 2019; 101116

• Björkström NK
• Ljunggren HG
• Michaëlsson J

Rising insights into pure killer cells in human peripheral tissues.

Nat Rev Immunol. 2016; 16: 310-320

• Jiang Y
• Wei X
• Guan J
• et al.

COVID-19 pneumonia: CD8⁺ T and NK cells are decreased in quantity however compensatory elevated in cytotoxic potential.

Clin Immunol. 2020; 218108516

• Marquardt N
• Kekäläinen E
• Chen P
• et al.

Human lung pure killer cells are predominantly comprised of extremely differentiated hypofunctional CD69⁻CD56^dim cells.

J Allergy Clin Immunol. 2017; 139: 1321-1330.e4

• Maucourant C
• Filipovic I
• Ponzetta A
• et al.

Pure killer cell immunotypes associated to COVID-19 illness severity.

Sci Immunol. 2020; 5eabd6832

• Nielsen SCA
• Yang F
• Jackson KJL
• et al.

Human B cell clonal growth and convergent antibody responses to SARS-CoV-2.

Cell Host Microbe. 2020; 28 (): 516

• Galson JD
• Schaetzle S
• Bashford-Rogers RJM
• et al.

Deep sequencing of B cell receptor repertoires from COVID-19 sufferers reveals robust convergent immune signatures.

Entrance Immunol. 2020; 11605170

• Robbiani DF
• Gaebler C
• Muecksch F
• et al.

Convergent antibody responses to SARS-CoV-2 in convalescent people.

Nature. 2020; 584: 437-442

• Zhu Z
• Chakraborti S
• He Y
• et al.

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.

Proc Natl Acad Sci USA. 2007; 104: 12123-12128

• Zhang H
• Wang G
• Li J
• et al.

Identification of an antigenic determinant on the S2 area of the extreme acute respiratory syndrome coronavirus spike glycoprotein able to inducing neutralizing antibodies.

J Virol. 2004; 78: 6938-6945

Potent neutralizing antibodies towards SARS-CoV-2 recognized by high-throughput single-cell sequencing of convalescent sufferers’ B cells.

Cell. 2020; 182: 73-84.e16

Human neutralizing antibodies elicited by SARS-CoV-2 an infection.

Nature. 2020; 584: 115-119

• Quinti I
• Lougaris V
• Milito C
• et al.

A potential function for B cells in COVID-19? Lesson from sufferers with agammaglobulinemia.

J Allergy Clin Immunol. 2020; 146: 211-213.e4

• Soresina A
• Moratto D
• Chiarini M
• et al.

Two X-linked agammaglobulinemia sufferers develop pneumonia as COVID-19 manifestation however get well.

Pediatr Allergy Immunol. 2020; 31: 565-569

• Montero-Escribano P
• Matías-Guiu J
• Gómez-Iglesias P
• Porta-Etessam J
• Pytel V
• Matias-Guiu JA

Anti-CD20 and COVID-19 in a number of sclerosis and associated problems: a case sequence of 60 sufferers from Madrid, Spain.

Mult Scler Relat Disord. 2020; 42102185

Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19.

Mult Scler Relat Disord. 2020; 41102135

• Treon SP
• Castillo JJ
• Skarbnik AP
• et al.

The BTK inhibitor ibrutinib could shield towards pulmonary harm in COVID-19-infected sufferers.

Blood. 2020; 135: 1912-1915

In protection of evidence-based drugs for the remedy of COVID-19 acute respiratory misery syndrome.

Ann Am Thorac Soc. 2020; 17: 787-789